| RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330 S Zhou, ON Obianom, J Huang, D Guo, H Yang, Q Li, Y Shu Pharmaceutics 15 (6), 1623, 2023 | | 2023 |
| A pharmacokinetic and plasmin-generation pharmacodynamic assessment of a tranexamic acid regimen designed for cardiac surgery with cardiopulmonary bypass ER Strauss, S Li, R Henderson, R Carpenter, D Guo, K Thangaraju, ... Journal of Cardiothoracic and Vascular Anesthesia 36 (8), 2473-2482, 2022 | 7 | 2022 |
| The protective effect of rabeprazole on cisplatin-induced apoptosis and necroptosis of renal proximal tubular cells S Chen, B Hu, Y Yang, Y He, L Yue, D Guo, T Wu, X Feng, Q Li, W Zhang, ... Biochemical and Biophysical Research Communications 612, 91-98, 2022 | 7 | 2022 |
| Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease H Liu, T Doke, D Guo, X Sheng, Z Ma, J Park, HMT Vy, GN Nadkarni, ... Nature genetics 54 (7), 950-962, 2022 | 97 | 2022 |
| Optimal Use of Intravenous Tranexamic Acid for Hemorrhage Prevention in Pregnant Women HK Ahmadzia, NLC Luban, S Li, D Guo, A Miszta, JVS Gobburu, ... Obstetric Anesthesia Digest 42 (2), 79-81, 2022 | | 2022 |
| A genetic-based population PK/PD modeling of methadone in chinese opiate dependence patients D Guo, Z Tan, X Lou, S Shi, Y Shu, H Zhou, L Yu, H Yang European Journal of Clinical Pharmacology, 1-14, 2022 | 2 | 2022 |
| Population pharmacokinetics and pharmacodynamics of Tranexamic acid in women undergoing caesarean delivery S Li, HK Ahmadzia, D Guo, E Dahmane, A Miszta, NLC Luban, JS Berger, ... British journal of clinical pharmacology 87 (9), 3531-3541, 2021 | 20 | 2021 |
| Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women HK Ahmadzia, NLC Luban, S Li, D Guo, A Miszta, JVS Gobburu, ... American journal of obstetrics and gynecology 225 (1), 85. e1-85. e11, 2021 | 38 | 2021 |
| Divergent regulation of OCT and MATE drug transporters by cadmium exposure H Yang, S Zhou, D Guo, ON Obianom, Q Li, Y Shu Pharmaceutics 13 (4), 537, 2021 | 5 | 2021 |
| RETRACTED: Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-catenin Downregulation and AMPK Activation S Zhou, ON Obianom, J Huang, D Guo, H Yang, Q Li, Y Shu Pharmaceutics 13 (3), 330, 2021 | 6 | 2021 |
| A pharmacokinetic and pharmacodynamic investigation of an ε-aminocaproic acid regimen designed for cardiac surgery with cardiopulmonary bypass ER Strauss, E Dahmane, M Judd, D Guo, B Williams, M Meyer, ... Journal of cardiothoracic and vascular anesthesia 35 (2), 406-417, 2021 | 13 | 2021 |
| Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy S Kalaria, S Williford, D Guo, Y Shu, C Medlin, M Li, SYA Yeung, F Ali, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41 (2 …, 2021 | 12 | 2021 |
| Lrp6 genotype affects individual susceptibility to nonalcoholic fatty liver disease and silibinin therapeutic response via Wnt/β-catenin-Cyp2e1 signaling LJ Chen, XX Lin, J Guo, Y Xu, SX Zhang, D Chen, Q Zhao, J Xiao, ... International Journal of Biological Sciences 17 (14), 3936, 2021 | 3 | 2021 |
| Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330 S Zhou, ON Obianom, J Huang, D Guo, H Yang, Q Li, Y Shu s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery A Miszta, HK Ahmadzia, NLC Luban, S Li, D Guo, LA Holle, JS Berger, ... Journal of Thrombosis and Haemostasis 19 (1), 221-232, 2021 | 34 | 2021 |
| Cadmium exposure enhances organic cation transporter 2 trafficking to the kidney membrane and exacerbates cisplatin nephrotoxicity H Yang, J Tang, D Guo, Q Zhao, J Wen, Y Zhang, ON Obianom, S Zhou, ... Kidney international 97 (4), 765-777, 2020 | 15 | 2020 |
| Lack of Association of Generic Brittle Status with Genetics and Physiologic Measures in Patients with Epilepsy S Das, D Guo, X Jiang, W Jiang, Y Shu, TY Ting, JE Polli Pharmaceutical Research 37, 1-14, 2020 | 2 | 2020 |
| Pyrazole-4-Carboxamide (YW2065): A therapeutic candidate for colorectal cancer via dual activities of Wnt/β-Catenin signaling inhibition and AMP-Activated protein kinase (AMPK … W Yang, Y Li, Y Ai, ON Obianom, D Guo, H Yang, S Sakamuru, M Xia, ... Journal of medicinal chemistry 62 (24), 11151-11164, 2019 | 35 | 2019 |
| The LRP6 functional mutation rs2302685 contributes to individual susceptibility to alcoholic liver injury related to the Wnt/β-catenin-TCF1-CYP2E1 signaling pathway Y Xu, D Chen, XX Lin, Q Zhao, J Guo, L Chen, W Zhang, J Xiao, GH Lian, ... Archives of toxicology 93, 1679-1695, 2019 | 15 | 2019 |
| Triazole-based inhibitors of the Wnt/β-Catenin signaling pathway improve glucose and lipid metabolisms in diet-induced obese mice ON Obianom, Y Ai, Y Li, W Yang, D Guo, H Yang, S Sakamuru, M Xia, ... Journal of medicinal chemistry 62 (2), 727-741, 2019 | 21 | 2019 |
